BioPharma articles

Charles River Laboratories International Galapagos Transaction Update

Charles River Laboratories International Galapagos Transaction Update

On March 13 Charles River announced the acquisition of Galapagos NV’s CRO services businesses: Argenta and BioFocus. To finance the acquisition, Charles River used a combination of cash and debt from its existing euro-denominated revolving credit facility. As a result, we estimate 2014 interest expense will increase by $2.8 million, to $9.6 million. CRL trades

Bottomline Technologies, Inc. Andera Acquisition Positive Addition to Commercial Banking Solutions

Yesterday, Bottomline Technologies announced that it agreed to purchase Andera, a provider of customer acquisition solutions for banks and credit unions. The company has over 500 customers and has helped process more than 4.5 million new account applications. More specifically this offering will pair with the recent Intuit acquisition and will focus on providing commercial

The Ultimate Software Group Seminar Reiterates Why Customers Are Choosing UltiPro

Last week Ultimate Software provided prospective customers the opportunity to view demonstrations of the product, learn more about Ultimate Software, and network with other companies facing similar HR and payroll challenges. The seminar was well attended, with roughly 25 attendees. Most of the attendees we spoke with were looking to replace existing ADP or Ceridian

ICON Acquisition of Aptiv Solutions Consistent With Strategy

Monday, March 31, ICON announced its intention to acquire Aptiv Solutions, a provider of global outsourced development services, for roughly $145 million. The company focuses on technology to enable adaptive clinical trials—a nice complement to ICON’s existing software offering through Firecrest and ICONIK. In addition, Aptiv owns an oncology focused full service CRO in Japan.

Cardinal Health, Inc. Expanding Preferred Products Platform With AccessClosure Acquisition

On Wednesday afternoon, April 2, Cardinal Health announced the acquisition of AccessClosure, a leading U.S. manufacturer of extravascular closure devices. Strategically, this deal provides Cardinal with a platform to expand its preferred products business into another physician preference category—cardiovascular  

Top